IVDR 3 answers

Is it permissible to provide access to a DiGA app before insurance approval?

Anonymous · Published December 24, 2025 · 1 comment
We are developing a DiGA app and would like to allow users to start using the app before their insurance company has approved their access (i.e., before they receive the code that allows us to invoice the insurance). Our reasoning is that the insurance approval process can take a while, and we want to prevent users from becoming frustrated or losing interest while waiting for approval. We understand that this carries the risk of not being paid if insurance denies access, but we are willing to accept that risk.
From a regulatory perspective, is it allowed to provide users with access to a DiGA app before they have received insurance approval?

Join the discussion. Leave a comment. Guest comments are welcome — add your email to get reply notifications.

Anonymous 6 months ago
This question is about regulatory compliance, not reimbursement or commercial risk.
Reply to this comment

Discussion

3 Answers

Accepted answer Dr. Oliver Eidel · Founder & CEO, OpenRegulatory ·
If your DiGA app is CE-marked and complies with MDR, you can make it available to users based on the intended purpose, regardless of insurance approval. DiGA status affects reimbursement by health insurance, not the ability to put the app on the market. However, you should not expect insurance to pay for users who access the app before official DiGA listing or without a prescription.

Join the discussion. Leave a comment. Guest comments are welcome — add your email to get reply notifications.

No comments yet. Be the first to share your thoughts.

A
Anonymous ·
Some DiGA apps, like Kalmeda, use a freemium model where users can access the app before insurance approval. However, be aware that you cannot use emails or push notifications to encourage non-DiGA users to convert to DiGA users or seek a prescription, as this may be considered advertising under current regulations.

Join the discussion. Leave a comment. Guest comments are welcome — add your email to get reply notifications.

No comments yet. Be the first to share your thoughts.

A
Anonymous ·
The main regulatory requirement is that if your app is considered a medical device, it must comply with the MDR. The MDR does not specify when or how payment is made, only that the device meets the necessary standards. So, from a regulatory standpoint, providing access before insurance approval is allowed as long as your device is compliant.

Join the discussion. Leave a comment. Guest comments are welcome — add your email to get reply notifications.

No comments yet. Be the first to share your thoughts.

Want to add your answer to this question?
Write an answer under your name by logging in or signing up, or post anonymously.

Still have a question? Ask a question here publicly — for free.

Or talk to one of our consultants — first calls are free. Check out our services and prices.

Looking to automate your regulatory work? Check out our eQMS, Formwork. Built for lean, founder-led companies. There’s a free version too.